ClinicalTrials.govpublic full text
Olaparib and High-Dose Chemotherapy in Treating Patients With Relapsed or Refractory Lymphomas Undergoing Stem Cell Transplant
recurrent diffuse large b-cell lymphoma, recurrent t-cell non-hodgkin lymphoma, refractory diffuse large b-cell lymphoma, refractory hodgkin lymphoma, refractory t-cell non-hodgkin lymphoma
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 154662
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.